Science in the City: Review of Treatments for Viral Hepatitis and an Update on Evolving Therapies for Chronic Liver Diseases

Saturday, July 15, 2023, 7:30 AM - 5:00 PM, Leon & Norma Hess Center for Science and Medicine, Davis Auditorium, 1470 Madison Avenue, New York, NY


Science in the City is a one day course with plenary sessions, specialized breakout sessions, and panel discussions which will provide a comprehensive update on the evolving therapies for Chronic Liver Diseases.

1. Summarize drug induced liver injury
2. Describe the multidisciplinary approach in the management of HCV and progress toward cure of HBV and HDV
3. Review the role of Artificial Intelligence in Liver Disease
4. Discuss new guidelines on the treatment of NASH and new therapeutics in development

Registration Fees:
By May 15, 2023
Physicians $200.00
Allied Health Professionals $125.00
Fellows & Residents $50.00
MSHS Physicians $150.00
MSHS Allied Health Professionals $50.00
MSHS Residents & Fellows $25.00

After May 15, 2023
Physicians $225.00
Allied Health Professionals $150.00
Fellows & Residents $75.00
MSHS Physicians $175.00
MSHS Allied Health Professionals $75.00
MSHS Residents & Fellows $50.00

While registering, please be sure to select your Lunch Breakout Session
Portal Vein Thrombosis
To TIPS or not to TIPS
Fibroscan Use in HBV/HCV/NASH
Autoimmune Liver Diseases: AIH/PSC/PBC
Artificial Intelligence in Liver Disease
Updates in Pediatric Hepatology: From the Adenovirus to Developments in Liver Disease Treatment in Children

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

For discounted hotel reservations, please contact our housing manager: Denise Newman She can be reached via email: [email protected] and via phone: 718-835-4911.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of Icahn School of Medicine at Mount Sinai (ISMMS) to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-accredited educational activities. All faculty participating in the planning or implementation of an activity accredited by ISMMS are expected to disclose all of their financial relationships with ineligible companies existing within the prior 24 months. Relevant financial relationships will be mitigated and disclosed to learners before the activity takes place. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Saturday, July 15, 2023